FI83308C - Foerfarande foer framstaellning av terapeutiskt aktiva dihydropyridinderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva dihydropyridinderivat. Download PDF

Info

Publication number
FI83308C
FI83308C FI851857A FI851857A FI83308C FI 83308 C FI83308 C FI 83308C FI 851857 A FI851857 A FI 851857A FI 851857 A FI851857 A FI 851857A FI 83308 C FI83308 C FI 83308C
Authority
FI
Finland
Prior art keywords
formula
compound
sub
methyl
preparation
Prior art date
Application number
FI851857A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI851857L (fi
FI851857A0 (fi
FI83308B (fi
Inventor
Peter Edward Cross
Simon Fraser Campbell
David Alker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI851857A0 publication Critical patent/FI851857A0/fi
Publication of FI851857L publication Critical patent/FI851857L/fi
Application granted granted Critical
Publication of FI83308B publication Critical patent/FI83308B/fi
Publication of FI83308C publication Critical patent/FI83308C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI851857A 1984-05-12 1985-05-10 Foerfarande foer framstaellning av terapeutiskt aktiva dihydropyridinderivat. FI83308C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848412208A GB8412208D0 (en) 1984-05-12 1984-05-12 Quinolone inotropic agents
GB8412208 1984-05-12

Publications (4)

Publication Number Publication Date
FI851857A0 FI851857A0 (fi) 1985-05-10
FI851857L FI851857L (fi) 1985-11-13
FI83308B FI83308B (fi) 1991-03-15
FI83308C true FI83308C (fi) 1991-06-25

Family

ID=10560892

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851857A FI83308C (fi) 1984-05-12 1985-05-10 Foerfarande foer framstaellning av terapeutiskt aktiva dihydropyridinderivat.

Country Status (25)

Country Link
US (1) US4654353A (ja)
EP (1) EP0161917B1 (ja)
JP (1) JPS60246368A (ja)
KR (1) KR880000131B1 (ja)
AT (1) ATE50988T1 (ja)
AU (1) AU554257B2 (ja)
CA (1) CA1278573C (ja)
DD (1) DD235867A5 (ja)
DE (1) DE3576499D1 (ja)
DK (1) DK162982C (ja)
ES (2) ES8609252A1 (ja)
FI (1) FI83308C (ja)
GB (1) GB8412208D0 (ja)
GR (1) GR851130B (ja)
HU (1) HU194172B (ja)
IE (1) IE57751B1 (ja)
IL (1) IL75165A (ja)
NO (1) NO851886L (ja)
NZ (1) NZ212033A (ja)
PH (1) PH20931A (ja)
PL (1) PL253328A1 (ja)
PT (1) PT80427B (ja)
SU (1) SU1417795A3 (ja)
YU (1) YU78085A (ja)
ZA (1) ZA853543B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
GB8709447D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Dihydropyridines
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
DE3311005A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0164247B1 (en) * 1984-06-07 1989-01-11 Pfizer Limited Dihydropyridines

Also Published As

Publication number Publication date
ES8703429A1 (es) 1987-02-16
FI851857L (fi) 1985-11-13
ES543033A0 (es) 1986-09-01
EP0161917B1 (en) 1990-03-14
DD235867A5 (de) 1986-05-21
GR851130B (ja) 1985-11-25
HU194172B (en) 1988-01-28
IE57751B1 (en) 1993-03-24
GB8412208D0 (en) 1984-06-20
JPH0529029B2 (ja) 1993-04-28
CA1278573C (en) 1991-01-02
DK162982C (da) 1992-06-01
PT80427B (en) 1987-04-16
NO851886L (no) 1985-11-13
IL75165A0 (en) 1985-09-29
FI851857A0 (fi) 1985-05-10
PT80427A (en) 1985-06-01
DE3576499D1 (en) 1990-04-19
ZA853543B (en) 1986-12-30
US4654353A (en) 1987-03-31
KR880000131B1 (ko) 1988-03-12
DK162982B (da) 1992-01-06
HUT37756A (en) 1986-02-28
DK207885D0 (da) 1985-05-10
KR850008156A (ko) 1985-12-13
PL253328A1 (en) 1986-06-03
JPS60246368A (ja) 1985-12-06
SU1417795A3 (ru) 1988-08-15
DK207885A (da) 1985-11-13
IE851168L (en) 1985-11-12
ES550965A0 (es) 1987-02-16
ES8609252A1 (es) 1986-09-01
AU4226985A (en) 1985-11-14
FI83308B (fi) 1991-03-15
EP0161917A3 (en) 1987-12-02
AU554257B2 (en) 1986-08-14
YU78085A (en) 1988-02-29
EP0161917A2 (en) 1985-11-21
ATE50988T1 (de) 1990-03-15
IL75165A (en) 1988-09-30
NZ212033A (en) 1988-02-12
PH20931A (en) 1987-06-05

Similar Documents

Publication Publication Date Title
US4792561A (en) Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
US4988690A (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
IT8222620A1 (it) Diidropiridine dotate di azione inotropa positiva, nuovi composti, loro impiego in prodotti medicinali e procedimento per la loro preparazione
US5670525A (en) Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
HU207314B (en) Process for producing 6-benzoxazinyl- and 6-benzthiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions containing them
FI83308C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva dihydropyridinderivat.
KR890004144B1 (ko) 1,4 - 디히드로피리딘 유도체의 제조방법
US4640922A (en) 3N-substituted 3,4-dihydropyrimidines as agents for treating disorders of cardiovascular system
EP0164247B1 (en) Dihydropyridines
US4652573A (en) Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4677101A (en) Substituted dihydroazepines useful as calcium channel blockers
US4892881A (en) Dihydropyridine anti-ischaemic and antihypertensive agents
US4845113A (en) 2-substituted -1,4-dihydropyridines and pharmaceutical compositions containing them
US4861782A (en) Certain 2h-benzo[a]quinolizin-2-yl-aminoalkyl esters of 1,4-dihydro-3,5-pyridinedicarboxylates useful for treating circulation disorders
US4876255A (en) Substituted 1,4-dihydropyridines for control of circulation and thromboses
US4600719A (en) Tetrahydropyridine and piperidine derivatives
US4579851A (en) Substituted and bridged tetrahydropyridines useful as calcium entry blockers
US4957930A (en) Dihydropyridine derivatives
US4015006A (en) 3(2H)-Isoquinolones therapeutic process
JPH0466233B2 (ja)
JPH0534352B2 (ja)
US4935548A (en) 1.4-dihydropyridines
NL8000571A (nl) Nieuwe derivaten van 4-amino-2-piperidinochinazoline.
US4794181A (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines
CS271495B2 (en) Method of new dihydropyridinamides production

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER CORPORATION